FFCP PHASE1:Mm9::chr10:95648354..95648360,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr10:95648354..95648360,-|id=chr10:95648354..95648360,-|ontology_enrichment_celltype=CL:0000355!2.19e-07!9|ontology_enrichment_celltype_v019_2=CL:0000355,1.20e-08,9|ontology_enrichment_disease=DOID:0060100!3.89e-20!3;DOID:4045!3.89e-20!3;DOID:0050686!1.33e-10!6|ontology_enrichment_disease_v019_2=DOID:0060100,8.72e-24,3;DOID:4045,8.72e-24,3;DOID:0050686,1.84e-12,6|ontology_enrichment_uberon=UBERON:0001134!2.19e-07!9;UBERON:0002036!2.19e-07!9;UBERON:0002385!2.19e-07!9;UBERON:0000486!2.19e-07!9;UBERON:0001015!2.19e-07!9;UBERON:0004290!2.19e-07!9;UBERON:0003082!2.19e-07!9;UBERON:0000383!9.74e-07!10|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.20e-08,9;UBERON:0002036,1.20e-08,9;UBERON:0002385,1.20e-08,9;UBERON:0000486,1.20e-08,9;UBERON:0007503,1.20e-08,9;UBERON:0001015,1.20e-08,9;UBERON:0002329,1.20e-08,9;UBERON:0003082,1.20e-08,9;UBERON:0003059,1.20e-08,9;UBERON:0007282,1.20e-08,9;UBERON:0004290,1.20e-08,9;UBERON:0009618,1.20e-08,9;UBERON:0000383,7.02e-08,10;UBERON:0007524,3.00e-07,11;UBERON:0003077,3.00e-07,11;UBERON:0007285,3.00e-07,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202475267389826,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.25559489221072,4.6880120671428,0,11.1763982725893,6.83045484958446,4.85510353031154,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr10:95648354..95648360,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr10:95648354..95648360,- | |||
|description=CAGE_peak_at_chr10:95648354..95648360,- | |||
|id=chr10:95648354..95648360,- | |||
|ontology_enrichment_celltype=CL:0000355!2.19e-07!9 | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,1.20e-08,9 | |||
|ontology_enrichment_disease=DOID:0060100!3.89e-20!3;DOID:4045!3.89e-20!3;DOID:0050686!1.33e-10!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,8.72e-24,3;DOID:4045,8.72e-24,3;DOID:0050686,1.84e-12,6 | |||
|ontology_enrichment_uberon=UBERON:0001134!2.19e-07!9;UBERON:0002036!2.19e-07!9;UBERON:0002385!2.19e-07!9;UBERON:0000486!2.19e-07!9;UBERON:0001015!2.19e-07!9;UBERON:0004290!2.19e-07!9;UBERON:0003082!2.19e-07!9;UBERON:0000383!9.74e-07!10 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.20e-08,9;UBERON:0002036,1.20e-08,9;UBERON:0002385,1.20e-08,9;UBERON:0000486,1.20e-08,9;UBERON:0007503,1.20e-08,9;UBERON:0001015,1.20e-08,9;UBERON:0002329,1.20e-08,9;UBERON:0003082,1.20e-08,9;UBERON:0003059,1.20e-08,9;UBERON:0007282,1.20e-08,9;UBERON:0004290,1.20e-08,9;UBERON:0009618,1.20e-08,9;UBERON:0000383,7.02e-08,10;UBERON:0007524,3.00e-07,11;UBERON:0003077,3.00e-07,11;UBERON:0007285,3.00e-07,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202475267389826,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.25559489221072,4.6880120671428,0,11.1763982725893,6.83045484958446,4.85510353031154,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr10:95648354..95648360,- | |||
}} |
Latest revision as of 02:00, 5 August 2015
Short description: | p@chr10:95648354..95648360, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr10:95648354..95648360, - |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 1.20e-08 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 1.20e-08 | 9 |
striated muscle tissue | 1.20e-08 | 9 |
muscle tissue | 1.20e-08 | 9 |
multilaminar epithelium | 1.20e-08 | 9 |
epithelial vesicle | 1.20e-08 | 9 |
musculature | 1.20e-08 | 9 |
somite | 1.20e-08 | 9 |
myotome | 1.20e-08 | 9 |
presomitic mesoderm | 1.20e-08 | 9 |
presumptive segmental plate | 1.20e-08 | 9 |
dermomyotome | 1.20e-08 | 9 |
trunk paraxial mesoderm | 1.20e-08 | 9 |
musculature of body | 7.02e-08 | 10 |
dense mesenchyme tissue | 3.00e-07 | 11 |
paraxial mesoderm | 3.00e-07 | 11 |
presumptive paraxial mesoderm | 3.00e-07 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 8.72e-24 | 3 |
muscle cancer | 8.72e-24 | 3 |
organ system cancer | 1.84e-12 | 6 |